📰 Resolution Bioscience Inc News
Resolution Bioscience Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Resolution Bioscience Inc. Real-time updates on events, politics, business and more.
May 29, 2024
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The
February 13, 2024
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The
February 9, 2024
/PRNewswire/ -- The "Next-Generation Sequencing: Emerging Clinical Applications and Global Markets" report has been added to ResearchAndMarkets.coms offering....
September 4, 2023
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Global Market Report 2023" report has been added to ResearchAndMarkets.com's...
May 29, 2023
/PRNewswire/ -- The "Multicancer Screening Market - A Global and Regional Analysis: Focus on Test Type, Technology, Sample, Method, Cancer Type, Application,...
November 30, 2022
/PRNewswire/ -- The "Metagenomics Market Size, Share & Trends Analysis Report by Technology (Shotgun Sequencing, 16S Sequencing), by Product, by Workflow, by...
July 21, 2022
/PRNewswire/ -- According to Coherent Market Insights, the global polymerase chain reaction market is estimated to be valued at US$ 5,627.9 million in 2022 and...
May 11, 2022
/PRNewswire/ -- The global NGS sample preparation market was worth around $1,598.8 million in 2021, and it is expected to reach $5,501.2 million by 2030,...
April 12, 2021
Share this article Share this article ResearchAndMarkets.coms offering. The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted). Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising fo...
March 3, 2021
Agilent to acquire Resolution Bioscience for $695 M Agilent to acquire Resolution Bioscience for $695 M 03 March 2021 | News Source credit: Shutterstock Agilent Technologies Inc has announced that it has entered into a definitive agreement to acquire Resolution Bioscience Inc, a leader in the development and commercialisation of next-generation sequencing (NGS)-based precision oncology solutions. The acquisition complements and expands Agilent’s capabilities in NGS-based cancer diagnostics a...